Axa (AXAHY)
(Delayed Data from OTC)
$38.00 USD
+0.83 (2.23%)
Updated Aug 23, 2024 03:59 PM ET
3-Hold of 5 3
B Value D Growth F Momentum C VGM
Income Statements
Fiscal Year end for Axa Sa falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 90,510 | 107,831 | 118,228 | 110,487 | 115,956 |
Cost Of Goods | 77,580 | 0 | 0 | 0 | 0 |
Gross Profit | 12,929 | 107,831 | 118,228 | 110,487 | 115,956 |
Selling & Adminstrative & Depr. & Amort Expenses | 6,318 | 101,509 | 133,340 | 124,018 | 144,524 |
Income After Depreciation & Amortization | 6,611 | 6,322 | -15,112 | -13,532 | -28,568 |
Non-Operating Income | -16,463 | -297 | -1,595 | -259 | -912 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 9,617 | 9,177 | 10,880 | 5,565 | 6,299 |
Income Taxes | 1,638 | 1,954 | 1,998 | 1,760 | 1,589 |
Minority Interest | 199 | 190 | 253 | 191 | 364 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 7,980 | 7,223 | 8,882 | 3,805 | 4,711 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | -27 |
Net Income (GAAP) | 7,781 | 7,034 | 8,628 | 3,614 | 4,319 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 6,002 | 6,150 | -14,082 | -12,188 | -27,027 |
Depreciation & Amortization (Cash Flow) | -608 | -172 | 1,029 | 1,343 | 1,541 |
Income After Depreciation & Amortization | 6,611 | 6,322 | -15,112 | -13,532 | -28,568 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 2,296.81 | 2,239.93 | 2,455.89 | 2,531.20 | 2,554.31 |
Diluted EPS Before Non-Recurring Items | 3.58 | 3.25 | 3.25 | 2.11 | 3.00 |
Diluted Net EPS (GAAP) | 3.39 | 2.98 | 3.51 | 1.43 | 1.69 |
Fiscal Year end for Axa Sa falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | NA | NA |
Cost Of Goods | NA | NA | NA | NA | NA |
Gross Profit | NA | NA | NA | NA | NA |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non-Operating Income | NA | NA | NA | NA | NA |
Interest Expense | NA | NA | NA | NA | NA |
Pretax Income | NA | NA | NA | NA | NA |
Income Taxes | NA | NA | NA | NA | NA |
Minority Interest | NA | NA | NA | NA | NA |
Investment Gains/Losses | NA | NA | NA | NA | NA |
Other Income/Charges | NA | NA | NA | NA | NA |
Income From Cont. Operations | NA | NA | NA | NA | NA |
Extras & Discontinued Operations | NA | NA | NA | NA | NA |
Net Income (GAAP) | NA | NA | NA | NA | NA |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | NA | NA | NA | NA |